Title: Christine Guenther: Innovator in Vascular Endothelium Protection
Introduction
Christine Guenther is an accomplished inventor based in Munich, Germany. She is currently associated with Apceth GmbH & Co. KG, where she focuses on innovative solutions in the field of vascular health. Although she has not yet been granted any patents, her work is significant in advancing medical technology.
Latest Patent Applications
Christine Guenther has filed several notable patent applications, including:
1. **Protection of the Vascular Endothelium from Immunologically Mediated Cytotoxic Reactions with Human CD34-Negative Progenitor Cells** - This application describes a method for protecting the vascular endothelium from CD8+ cytotoxic T-lymphocyte mediated reactions in subjects at risk of transplant-related complications. The method involves administering human CD34-negative progenitor cells to the subject.
2. **Protection of the Vascular Endothelium from Immunologically Mediated Cytotoxic Reactions with Human CD34-Negative Progenitor Cells** - This invention provides human CD34-negative progenitor cells for use in protecting the vascular endothelium from immunologically mediated cytotoxic reactions in subjects afflicted with vascular inflammatory disease. It also includes methods for producing these progenitor cells and determining their protective abilities.
Conclusion
Christine Guenther is making strides in the field of vascular health through her innovative patent applications. Her work has the potential to significantly impact the treatment of transplant-related complications and vascular inflammatory diseases.